We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Synosia Announces Positive Interim Results for a Potential Treatment for Parkinson’s Disease

News   Feb 01, 2010

 
Synosia Announces Positive Interim Results for a Potential Treatment for Parkinson’s Disease
 
 
 

RELATED ARTICLES

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

Technology Senses How Parkinson's Patients Respond to Medication

News

Researchers have developed an innovative way to automatically and reliably detect and monitor medication "on" and "off" states in Parkinson's disease patients.

READ MORE

Synthetic Peptide Inhibits Toxicity and Aggregation of Protein in Alzheimer's Disease

News

Alzheimer’s is a disease of aggregation. Neurons in the human brain make a protein called amyloid beta. Now, a team led by researchers at the University of Washington has developed synthetic peptides that target and inhibit those small, toxic aggregates.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE